Phospholipase A2--a mediator between proximal and distal effectors of inflammation - PubMed (original) (raw)

Review

Phospholipase A2--a mediator between proximal and distal effectors of inflammation

W Pruzanski et al. Immunol Today. 1991 May.

Abstract

Phospholipase A2 (PLA2) is known to play an important intracellular role in inflammatory processes but does it also perform a vital function extracellularly? Here, W. Pruzanski and P. Vadas marshall the evidence supporting PLA2 as a mediator of inflammation, specifically in linking local and systemic effects.

PubMed Disclaimer

Similar articles

• Proinflammatory effects of phospholipase A2 (PLA2) in several in vitro and in vivo systems.
  Chang J, Marshall LM, Carlson RP. Chang J, et al. Adv Prostaglandin Thromboxane Leukot Res. 1989;19:594-7. Adv Prostaglandin Thromboxane Leukot Res. 1989. PMID: 2526543 No abstract available.
• Phospholipase A2 regulates critical inflammatory mediators of multiple organ failure.
  Anderson BO, Moore EE, Banerjee A. Anderson BO, et al. J Surg Res. 1994 Feb;56(2):199-205. doi: 10.1006/jsre.1994.1032. J Surg Res. 1994. PMID: 8121178 Review.
• Brain phospholipases A2: a perspective on the history.
  Farooqui AA, Horrocks LA. Farooqui AA, et al. Prostaglandins Leukot Essent Fatty Acids. 2004 Sep;71(3):161-9. doi: 10.1016/j.plefa.2004.03.004. Prostaglandins Leukot Essent Fatty Acids. 2004. PMID: 15253885 Review.
• The role of phospholipase A2 in the physiopathology of osteoarthritis.
  Pruzanski W, Bogoch E, Wloch M, Vadas P. Pruzanski W, et al. J Rheumatol Suppl. 1991 Feb;27:117-9. J Rheumatol Suppl. 1991. PMID: 2027108
• Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes.
  Pruzanski W, Vadas P, Browning J. Pruzanski W, et al. J Lipid Mediat. 1993 Nov;8(3):161-7. J Lipid Mediat. 1993. PMID: 8268462 Review. No abstract available.

Cited by

• Exploring the association between circulating endothelial protein C receptor and disease activity of rheumatoid arthritis in a pilot study.
  Xue M, Lin H, Lynch T, Bereza-Malcolm L, Sinnathurai P, Thomas R, Keen H, Hill C, Lester S, Wechalekar M, March L. Xue M, et al. Rheumatol Adv Pract. 2024 Aug 6;8(3):rkae096. doi: 10.1093/rap/rkae096. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 39184533 Free PMC article.
• Synthesis and anti-inflammatory activity of benzimidazole derivatives; an in vitro, in vivo and in silico approach.
  Bano S, Nadeem H, Zulfiqar I, Shahzadi T, Anwar T, Bukhari A, Masaud SM. Bano S, et al. Heliyon. 2024 Apr 26;10(9):e30102. doi: 10.1016/j.heliyon.2024.e30102. eCollection 2024 May 15. Heliyon. 2024. PMID: 38726192 Free PMC article.
• Current trends in epigenetic, cellular and molecular pathways in management of rheumatoid arthritis.
  Makkar R, Sehgal A, Singh S, Sharma N, Rawat R, Rashid S, Vargas-De-La-Cruz C, Yadav S, Bungau SG, Behl T. Makkar R, et al. Inflammopharmacology. 2023 Aug;31(4):1577-1588. doi: 10.1007/s10787-023-01262-5. Epub 2023 Jun 19. Inflammopharmacology. 2023. PMID: 37335368 Review.
• Mastoparans: A Group of Multifunctional α-Helical Peptides With Promising Therapeutic Properties.
  de Santana CJC, Pires Júnior OR, Fontes W, Palma MS, Castro MS. de Santana CJC, et al. Front Mol Biosci. 2022 Jun 24;9:824989. doi: 10.3389/fmolb.2022.824989. eCollection 2022. Front Mol Biosci. 2022. PMID: 35813822 Free PMC article. Review.
• Old but New: Group IIA Phospholipase A2 as a Modulator of Gut Microbiota.
  Taketomi Y, Miki Y, Murakami M. Taketomi Y, et al. Metabolites. 2022 Apr 14;12(4):352. doi: 10.3390/metabo12040352. Metabolites. 2022. PMID: 35448539 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations